Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Research in Canada
Pfizer Global Medical Grants
UM Funding ID
FD03238
Sponsor
Pfizer Global Medical Grants
Category
International
Description
This competitive program seeks to support research in Canada that advances medical knowledge in the understanding, diagnosis and treatment of ATTR Amyloidosis. This is a call for a second wave of submissions for review. All projects submitted in the first wave will be reviewed according to the original timelines
Individual projects requesting up to $100,000 CAD will be considered. Pfizer anticipates awarding up to 3 grants.
VPRI Contact
Michelle Olivson
Contracts CoordinatorMichelle [dot] .Olivson [at] @umanitoba [dot] .ca
Deadlines
| UM Internal Deadline | Sponsor Deadline | |
|---|---|---|
Application | 21-Sep-2023 4:30 pm CST | 02-Oct-2023 11:59 pm EST |
Important
The information in this directory is provided as a service to the University Community and anyone with legitimate business with the University. Use of this directory to prepare mass mailings is prohibited.